Complete Mobile Drug Testing vs ScoliCare
Franchise Comparison 2026
FDDs: Complete Mobile Drug Testing 2026, ScoliCare 2025SBA 7(a) data through FY2026Updated How we score
Not like-for-like: these figures come from FDDs of different years (2025, 2026). Costs, fees and unit counts change from one filing to the next, so the older column may be out of date.
Both Complete Mobile Drug Testing and ScoliCare are franchises in the healthcare category. Complete Mobile Drug Testing requires an investment of $68K – $288K while ScoliCare requires $162K – $246K. In terms of revenue, ScoliCare reports higher average gross sales at $890K. FranchiseVerdict rates Complete Mobile Drug Testing B (Second tier) and ScoliCare B (Second tier).
| Metric | Complete Mobile Drug Testing | ScoliCare |
|---|---|---|
| Verdict Grade | ||
| Investment Range | $68K – $288K | $162K – $246K |
| Franchise Fee | $55K | $49K |
| Royalty Rate | 10.0% | 5.0% |
| Average Gross Sales (Item 19) | $889KCompany-owned only · n=1 | $890K |
| SBA Charge-Off Rate | N/A | N/A |
| Total Units | 1 | 4 |
| Unit Growth (YoY) | +0 units | +1 units |
| Year Began Franchising | 2025 | 2021 |
| FDD Year | 2026 | 2025 |
Investment Range
$68K – $288K
$162K – $246K
Franchise Fee
$55K
$49K
Royalty Rate
10.0%
5.0%
Average Gross Sales (Item 19)
$889KCompany-owned only · n=1
$890K
SBA Charge-Off Rate
N/A
N/A
Total Units
1
4
Unit Growth (YoY)
+0 units
+1 units
Year Began Franchising
2025
2021
FDD Year
2026
2025
Next step
Browse free
Every brand with an FDD on file, graded, with costs, disclosed sales and SBA records. No sign-in.Pro
For advisors and lenders working across many brands; inquire by email.